Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

HEXO to Report Q1 2022 Financial Results and Host Investor Webcast

Read more ››
By: GlobenewsWire - 07 Dec 2021
Related companies:  HEXO Corp.

Clene Nanomedicine’s RESCUE-ALS Phase 2 Results Selected for Late-Breaking Presentation at 32nd International Symposium on ALS/MND

Read more ››
By: GlobenewsWire - 07 Dec 2021
Related companies:  Clene Inc.

MediPharm Labs Announces Changes to Board of Directors

Read more ››
By: GlobenewsWire - 07 Dec 2021
Related companies:  MediPharm Labs Corp.

Prometheus Biosciences Reports Positive Topline Phase 1 Data on Lead Therapeutic Candidate PRA023; Expands Indications to Include Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)

Read more ››
By: GlobenewsWire - 07 Dec 2021
Related companies:  Prometheus Biosciences, Inc.

Jushi Holdings Inc. Announces Participation in Upcoming Conferences in December 2021

Read more ››
By: GlobenewsWire - 07 Dec 2021

Advicenne announces significant progress in marketing its lead product Sibnayal™ in Europe

Read more ››
By: GlobenewsWire - 07 Dec 2021
Related companies:  Advicenne

CorVel Launches New Workers’ Compensation and Liability Solution, Leveraging Artificial Intelligence and Predictive Analytics

Read more ››
By: GlobenewsWire - 07 Dec 2021

Aurora Spine Corporation to Participate in the Lytham Partners Winter 2021 Investor Conference

Read more ››
By: GlobenewsWire - 07 Dec 2021
Related companies:  Aurora Spine Corporation

Arbutus Biopharma, X-Chem and Proteros biostructures Achieve First Milestone Under COVID-19 Discovery Research and License Agreement

Read more ››
By: GlobenewsWire - 07 Dec 2021
Related companies:  Arbutus Biopharma Corporation

Harpoon Therapeutics to Host Pipeline Update Call and Webcast on December 13, 2021

Read more ››
By: GlobenewsWire - 07 Dec 2021
Related companies:  Harpoon Therapeutics, Inc.

Science 37® Furthers Global Expansion with Capabilities in China and Russia to Advance Decentralized Clinical Trials and Accelerate Development

Read more ››
By: GlobenewsWire - 07 Dec 2021
Related companies:  Science 37, Inc.

Healthcare Triangle to Present at Sidoti December Virtual Microcap Conference

Read more ››
By: GlobenewsWire - 07 Dec 2021

Clover Signs COVID-19 Vaccine Supply Agreement with UNICEF

Read more ››
By: GlobenewsWire - 07 Dec 2021
Related companies:  Sichuan Clover Biopharmaceuticals, Inc.

Vaccitech reports promising interim efficacy analysis in Phase 1b/2a clinical study in chronic HBV

Read more ››
By: GlobenewsWire - 07 Dec 2021
Related companies:  Nykode Therapeutics AS | Vaccitech Limited

Enlivex Receives Regulatory Authorization to Expand its Phase II Sepsis Trial into Greece

Read more ››
By: GlobenewsWire - 07 Dec 2021
Related companies:  Enlivex Therapeutics Ltd.

Vincerx Pharma Receives Orphan Drug Designation from European Commission for VIP152 for the Treatment of Diffuse Large B-Cell Lymphoma

Read more ››
By: GlobenewsWire - 07 Dec 2021
Related companies:  Vincerx Pharma, Inc.

Aligos Presents Update of Chronic Hepatitis B Pipeline Portfolio at HEP DART 2021

Read more ››
By: GlobenewsWire - 07 Dec 2021
Related companies:  Aligos Therapeutics, Inc.

Recce Pharmaceuticals Announces Update on Phase I/II Clinical Trial for the Treatment of Burn Wound Infections

Read more ››
By: GlobenewsWire - 07 Dec 2021
Related companies:  Recce Pharmaceuticals Ltd

PepGen Appoints Vice President of Program Management and Promotes Sonia Bracegirdle, Ph.D., to Senior Vice President, Strategy & Operations

Read more ››
By: GlobenewsWire - 07 Dec 2021
Related companies:  PepGen Inc

Fortress Biotech, Cyprium Therapeutics and Sentynl Therapeutics Announce the Initiation of Rolling Submission of a New Drug Application for CUTX-101, Copper Histidinate, for Treatment of Menkes Disease

Read more ››
By: GlobenewsWire - 07 Dec 2021
Related companies:  Fortress Biotech, Inc. (New York)
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑